David Cosgrove
BC Cancer Agency(CA)Compass Oncology(US)Northwestern Medicine(US)The US Oncology Network(US)Nebraska Cancer Specialists(US)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Colorectal Cancer Treatments and Studies, Cholangiocarcinoma and Gallbladder Cancer Studies, Cancer Genomics and Diagnostics, Cancer Mechanisms and Therapy
Most-Cited Works
- → Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial(2018)2,497 cited
- → Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA(2020)1,444 cited
- → Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma(2011)307 cited
- → Pattern of distant metastases in colorectal cancer: a SEER based study(2015)251 cited
- → Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors(2014)195 cited
- → Intrahepatic Cholangiocarcinoma: Management Options and Emerging Therapies(2013)174 cited